(RTTNews) - Stereotaxis, Inc. (STXS), a pioneer in surgical robotics, announced Tuesday it obtained U.S. Food and Drug Administration (FDA) approval for the MAGiC Magnetic Interventional Ablation ...

Pulsed-field ablation, transcatheter heart valves, and IVL are among the top stories, as they drive growth among the largest ...

Abbott supported its CE mark approval with data from its FOCALFLEX CE mark study. The global clinical trial, conducted across ...

With nine new procedures cleared for the da Vinci 5 robot, Intuitive’s strategy includes working with a limited number of U.S ...

ST. LOUIS - Stereotaxis (NYSE:STXS) announced Tuesday it has received U.S. Food and Drug Administration (FDA) approval for its MAGiC Magnetic Interventional Ablation Catheter. The $220 million market ...

Stereotaxis has won FDA approval for the MAGiC Magnetic Interventional Ablation Catheter. The device is a robotically navigated magnetic ablation catheter designed to perform cardiac ablation ...

ST. LOUIS, Jan. 06, 2026 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced it obtained ...

Investing.com -- Stereotaxis (NYSE:STXS) stock surged 8.3% Tuesday after the surgical robotics company announced it received U.S. Food and Drug Administration (FDA) approval for its MAGiC Magnetic ...

Stereotaxis has received the US Food and Drug Administration (FDA) approval for its MAGiC ablation catheter, permitting its use in cardiac ablation procedures. The MAGiC Magnetic Interventional ...